YOYu.S. Osadchuk

Yu.S. Osadchuk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yu.S. Osadchuk has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    STUDY OF STAKEHOLDER INTEREST IN IMPROVING SPECIALISTS TRAINING FOR THE LABORATORY INDUSTRY

    by Y.S. Osadchuk, T.A. Vezhnovets, I.S. Tanasiichuk, L.V. Natrus

    Background. The level of stakeholder involvement in the creation of an educational program (EP) for training specialists, the content of academic disciplines, their implementation, analysis of the effectiveness of training, assimilation of knowledge by applicants, etc. is very low. The success of training personnel for the laboratory can be significantly increased with the real participation of stakeholders in the educational process and their interest in the direct training of applicants. Aim: analyze stakeholders' attitudes towards participation in the educational process and their interest in development laboratory diagnostics ЕР to develop ways to effectively involve employers in improving the competencies of applicants. Materials and methods. The sociological study was conducted in the form of an anonymous questionnaire of 106 laboratory workers (laboratory assistants and specialists). The questionnaire was distributed among healthcare institutions that are identified and approved by the Ministry of Health of Ukraine as internship bases for interns. Employees of private laboratories that have an agreement on cooperation in the field of educational services with an educational institution will also be involved. Results. More than 70% of the study participants believe that the readiness of applicants for independent work is determined not only by the quality of education, but also by the influence of mentors. The vast majority (90%) agree that involving laboratory employees in teaching contributes to their professional development. Almost 80% of respondents consider the participation of employers in the formation and improvement of educational programs to be critically important or appropriate. However, every fifth one expresses doubts about the ability and reality of such cooperation. 66.7% of stakeholders agree to participate in the pedagogical process and 5% want to teach, but a third of participants do not plan to get involved. The following key obstacles to effective cooperation and the development of partnerships between laboratories and educational institutions were identified: excessive workload (76.9%), lack of cooperation experience (25.6%), and insufficient pedagogical competence (20.5%). Conclusion. To attract employers to improve the competencies of applicants in laboratory diagnostics, it is necessary to offer: optimization of workload and creation of conditions for a flexible combination of teaching and main activities; implementation of programs to improve pedagogical competence and mentoring; stimulation of participation in cooperation through material and non-material incentives; development of communication platforms between employers and educational institutions to coordinate the content and forms of training of future specialists.

  • Could the Propionic Acid Treatment in Combination with Metformin be Safe for the Small Intestine of Diabetic Rats?

    by Larysa Natrus, Olha Lisakovska, Anton Smirnov, Yuliia Osadchuk, Serhyi Savosko, Yuliia Klys

    Background: Effects of propionic acid (PA) on the cellular and molecular processes in the small intestine under type 2 diabetes mellitus (T2DM)-induced endoplasmic reticulum (ER) stress remain incompletely studied. Objectives: The aim of the study was to assess the state of unfolded protein response (UPR) system in the small intestine of diabetic rats and to explore PA’s influence on metformin treatment. Methods: Male Wistar rats were divided into 1) control and 2) T2DM groups, and groups receiving (14 days, orally) 3) metformin (60 mg/kg), 4) PA (60 mg/kg), and 5) PA+metformin. Western blotting, RT-PCR, and transmission electron microscopy were performed. Results: We found that T2DM induced elevation of ER intermembrane space and UPR overactivation based on increased GRP78, ATF6 and PERK levels in small intestine. Metformin treatment led to a further UPR activation. PA supplementation partially restored enterocytes functioning via normalization of ATF6 and PERK content, while IRE1 level reached the maximum value, compared to all groups. The most pronounced effect of adaptation to the T2DMinduced ER stress was observed after combined metformin and PA action. In particular, decreased ER intermembrane space in enterocytes was detected compared to separate metformin and PA administration, which was accompanied by restored GRP78, PERK and IRE1 levels. Conclusion: Our study proves the safety of additional therapy with propionic acid in combination with metformin for the functional state of small intestine. Due to its ability to modulate UPR signaling, PA may be considered a safe and perspective candidate for supportive therapy in T2DM, especially for neuroprotection.


  • Open Access

    Unfolded protein response in gastric glandulocytes of rats with the pharmacological correction of type 2 diabetes

    by Y.G. Klys, T.R. Kerimov, S.I. Savosko, Y.S. Osadchuk, S.M. Smirnov, L.V. Natrus

    Background. The cellular and molecular mechanisms underlying gastrointestinal complications caused by type 2 diabetes mellitus (T2DM) may involve accumulation of misfolded proteins in the endoplasmic reticulum that disrupts protein homeostasis and activates a signaling pathway termed the unfolded protein response (UPR). The goal of the present study was to assess the state of the UPR system in gastric glandulocytes of untreated and metformin- and propionate-treated T2DM rats. Materials and methods. Rats with induced T2DM received metformin, propionate, and their combination. Analysis of the levels of 78-kDa glucose-regulated protein (GRP78), activating transcription factor 6 (ATF6), protein kinase R-like endoplasmic reticulum kinase (PERK), and inositol-requiring enzyme 1 (IRE1) was performed by Western blotting and immunohistochemical assessment of slices. Results. In T2DM rats, an increase in GRP78 vs. control (normal) group was found. Metformin and propionate treatment led to an increase in GRP78; under combination therapy, its content was registered at the level in untreated T2DM group. An increase in the ATF6 in T2DM rats was found, and all treatment regimens contributed to its growth. The PERK level in T2DM rats exceeded that in controls, and propionate treatment caused its decrease to the level observed in control group. An immunohistochemical assessment revealed a tendency to increase the intensity of immunoreaction for GRP78 in T2DM rats. With metformin treatment, an intensive immunoreaction for GRP78 was revealed. The general trend in T2DM rats was a significant increase in ATF6 expression. Conclusions. Combination treatment with metformin and propionate led to a significant decrease in GRP78, which may indicate a positive effect of such therapy. New data on propionic acid effect on UPR in the stomach have been obtained that may be beneficial for developing possible treatment strategies in complications of gastropathy caused by diabetes.


  • Open Access

    Regulation of the apoptosis/autophagy switch by propionic acid in ventromedial hypothalamus of rats with type 2 diabetes mellitus

    by Larysa Natrus, Yuliia Osadchuk, Olha Lisakovska, Toralf Roch, Nina Babel, Yuliia Klys, Dmytro Labudzynskyi, Yuri Chaikovsky


  • Open Access

    Effect of Propionic Acid on Diabetes-Induced Impairment of Unfolded Protein Response Signaling and Astrocyte/Microglia Crosstalk in Rat Ventromedial Nucleus of the Hypothalamus

    by Larysa V. Natrus, Yulia S. Osadchuk, Olha O. Lisakovska, Dmytro O. Labudzinskyi, Yulia G. Klys, Yuri B. Chaikovsky

    Background. The aim was to investigate the influence of propionic acid (PA) on the endoplasmic reticulum (ER), unfolded protein response (UPR) state, and astrocyte/microglia markers in rat ventromedial hypothalamus (VMH) after type 2 diabetes mellitus (T2DM). Methods. Male Wistar rats were divided: (1) control, (2) T2DM, and groups that received the following (14 days, orally): (3) metformin (60mg/kg), (4) PA (60mg/kg), and (5) PA+metformin. Western blotting, RT-PCR, transmission electron microscopy, and immunohistochemical staining were performed. Results. We found T2DM-associated enlargement of ER cisterns, while drug administration slightly improved VMH ultrastructural signs of damage. GRP78 level was 2.1-fold lower in T2DM vs. control. Metformin restored GRP78 to control, while PA increased it by 2.56-fold and metformin+PAby 3.28-fold vs. T2DM. PERK was elevated by 3.61-fold in T2DM, after metforminby 4.98-fold, PA5.64-fold, and metformin+PA3.01-fold vs. control. A 2.45-fold increase in ATF6 was observed in T2DM. Metformin decreased ATF6 content vs. T2DM. Interestingly, PA exerted a more pronounced lowering effect on ATF6, while combined treatment restored ATF6 to control. IRE1 increased in T2DM (2.4-fold), metformin (1.99-fold), and PA (1.45-fold) groups vs. control, while metformin+PA fully normalized its content. The Iba1 level was upregulated in T2DM (5.44-fold) and metformin groups (6.88-fold). Despite PA treatment leading to a further 8.9-fold Iba1 elevation, PA+metformin caused the Iba1 decline vs. metformin and PA treatment. GFAP level did not change in T2DM but rose in metformin and PA groups vs. control. PA+metformin administration diminished GFAP vs. PA. T2DM-induced changes were associated with dramatically decreased ZO-1 levels, while PA treatment increased it almost to control values. Conclusions. T2DM-induced UPR imbalance, activation of microglia, and impairments in cell integrity may trigger VMH dysfunction. Drug administration slightly improved ultrastructural changes in VMH, normalized UPR, and caused an astrocyte activation. PA and metformin exerted beneficial effects for counteracting diabetes-induced ER stress in VMH.


  • Open Access

    THE PATHOGENETIC RATIONALE THE WAYS OF EXPERIMENTAL TYPE 2 DIABETES MELLITUS MODELING

    by L.V. Natrus, Yu.S. Osadchuk, D.O. Labudzinskyi, Yu.B. Chaikovsky, A.S. Smirnov

    Relevance. When modeling experimental type 2 diabetes mellitus (T2DM), various schools and research groups receive significant variability in tissue changes, which is difficult to compare and extrapolate as a specific pathogenic or pharmacological effect. The lack of standard operating procedures agreed upon in the scientific community greatly complicates the interpretation of the result. Therefore, the creation of a uniquely pathogenetic animal model of CD2 in animals is an urgent task. Objective. Determination of the complex of exogenous effects for the most efficient reproduction of the experimental model of T2DM in rats and the pathogenetic justification of the changes in the body to study the central mechanisms of homeostasis regulation and their pharmacological correction. Materials and methods. T2DM was model in rats by feeding a high-fat diet (HFD) with additional streptozotocin induction. The model was evaluated by anthropometric measurements, studies of biochemical parameters, an insulin tolerance test, analysis of the spectrum of fatty acids in the composition of tissues. Statistical data processing was performed with using the IBM SPSS Statistics 23. Results. The obtained data were compared with our studies of the lipid metabolism of patients with varying degrees of diabetic retinopathy on the background of T2DM and analysis of the information content of biochemical markers to assess lipid metabolic disturbances on the background of hyperglycemia in patients. It was found that the simulation in rats of experimental T2DM by a food load of HFD (45%) + fructose 20% for 3 months followed by a single induction of streptozotocin (25 mg/kg) causes changes in lipid and carbohydrate metabolism in animals similar changes which are in the human with a diagnosed long-term diabetes and the development of microvascular complications. Conclusion. We determined the optimal combination of effects and developed a consistent experimental load scheme that allows us to obtain a symptom model of type 2 diabetes in an animal experiment. Using the diagnostic algorithm, which includes physiological and laboratory methods, the degree of damage to organs and systems was determined, a comparison was made with the level of metabolic disorders in patients with T2DM and people without diabetes. The given model is a pathogenetically grounded approach for further study of the central mechanisms of homeostasis regulation and their pharmacological correction


  • Open Access

    FEATURES OF CHANGES IN FATTY ACIDS COMPOSITION OF TISSUES IN DIFFERENT MODELS OF EXPERIMENTAL TYPE 1 DIABETES

    by Yu.S. Osadchuk, Yu.B. Chaikovsky, L.V. Natrus, T.S. Bryuzgina

    Relevance. Alloxan and streptozotocin are used for experimental modeling of hyperglycemia. Damaged β-cells with these compounds lead to the reduction of synthesis and secretion of the level of insulin in the blood, as a result of which animals develop hyperglycemia and diabetic syndrome, similar to insulin-dependent type 1 diabetes. One of the methodological approaches for assessing the degree and development of tissue damage of vital organs, including diabetes, is the study of their fatty acid composition. But for the planning of an experiment with type 1 diabetes, it is necessary to take into account the discrepancy between the data obtained on different models. Objective. The aim of the work is to study the changes in the fatty acid composition of cardiomyocyte and hepatocyte lipids in type 1 diabetes of the rats which are created on different models: alloxan (Allox) and streptozotocin (STZ). Material and methods. In the experiment, the model of type 1 diabetes was developed by the single-dose administration of streptozotocin (50 mg/kg) and alloxane monohydrate in a dose of 130 mg/kg to white rats. Their administration caused a persistent hyperglycemia (20-34 mmol/L) to the majority of experimental animals. Research of the contents of 9 most informative fatty acids (FA) in the composition of the myocardium and liver homogenate was carried out by gas-vapor chromatography in the experimental laboratory of Scientific research institute. The statistical significance of differences in the meanings of the groups of comparisons was estimated by the Student's t-criterion. Results. In the Allox model, we discovered a significant (p<0,05) 2-fold decrease in the proportion of palmitic FA to 9,5±0,5% relative to the control group 18,6±1,0% and stearic liquid crystal to 5,5±0,6% relative to the control 11,1±1,0% in the hepatocytes than in to STZ model. Additionally, we observed, a 12-fold increase in the content of meristic FA and pentadecane FA from 0,1±0,05% in the control to 1,2 ±0,1% in rats with the Allox model of diabetes. Among the unsaturated FA a significant increase (p <0,05) of 2,4 times the growth of oleinic FA from 14,8±1,5% to 34,2±1,6%, and a significant (p<0,05) in 1,5 times reduction of arachidone FA from 30,1±1,5% in control to 19,6±1,0% in rats with diabetes in the liver could be noted. A significant increase (p<0,05) of oleinic FA from 15,1±0,7 in the control to 33,1±1,5% and a decrease of 1,3 times the linoleic FA from 28,8±1,0% in control to 21,8±2,0% in the Allox model of rats with 1 type diabetes was showed in the myocardium. On the other hand, the STZ model rats increased the content of linoleic acid to 34,9±1,0%, which was a significant (p<0,05) difference with the control and Allox model. It is believed that the discrepancy in data is due to different pathogenetic mechanisms of action of drugs on tissues, which become targets of damage. Conclusions. The Allox model of type 1 diabetes shows the aggressive effects of high-level radicals and can be successfully used to study the mechanisms of oxidative stress, which necessarily occurs in conditions of hyperglycemia. The development of the STZ model of diabetes reflects the less awful effects of cell's damage, and such simulations should be used in the study of tissue and organ disorders that occur with prolonged and persistent hyperglycemia.